Who owns Bufferin (United States)?
Bufferin (United States) is owned by Genomma Lab (Mexico, BMV: LAB), which has owned the brand since 2018.[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Key facts
- Current owner
- Genomma Lab Internacional, S.A.B. de C.V. reported
- Owned since
- Previous owner
- None recorded
- Owner HQ
- 🇲🇽 Mexico, Mexico City
- Origin
- 🇺🇸 United States
- Category
- Consumer health › Over-the-counter medicine › Pain relief
- Parent ticker
- BMV: LAB
- Last verified
- · 1 sources
About Bufferin (United States)
Bufferin is a buffered aspirin sold for headaches and migraines. Genomma Lab USA bought the United States rights to it from Dr Reddy's Laboratories in June 2018, in one of two transactions that also brought it Cheracol D and Rose Milk, as part of a push into the American over-the-counter market. Genomma also sells Bufferin in Chile. The name is held by different owners in other countries.
Ownership timeline of Bufferin (United States)
- 2018 – present Genomma Lab [1] reported
Where Bufferin (United States) sits in Genomma Lab
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Genomma Lab ownership tree →
Other brands owned by Genomma Lab in consumer health
Latest news about Bufferin (United States)
No tagged news items yet. Deals, regulatory actions and recalls are added from SEC filings, regulators and trade press; only titles and links are stored.
Headlines link to the original publisher. Brandtree does not reproduce article text.
Frequently asked questions
Who is the parent company of Bufferin (United States)?
The parent company of Bufferin (United States) is Genomma Lab, a publicly listed company headquartered in Mexico.
Is Bufferin (United States) American or Mexican?
Bufferin (United States) originated in the United States, but it is owned today by Genomma Lab, which is headquartered in Mexico. So Bufferin (United States) is an American-origin brand under Mexican ownership.
Since when has Genomma Lab owned Bufferin (United States)?
Genomma Lab has owned Bufferin (United States) since 2018.
Is Bufferin (United States) still owned by Genomma Lab?
Yes. As of 23 September 2026, Bufferin (United States) is still owned by Genomma Lab. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Genomma Lab Internacional — Reporte Anual 2025 (Anexo N, BMV) — Genomma Lab Internacional, S.A.B. de C.V., Annual report; retrieved 23 September 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.